Skip to main content

Table 1 Reported cases of primary alveolar rhabdomyosarcoma of the bone so far without identifiable soft tissue component

From: Primary alveolar rhabdomyosarcoma of the bone: two cases and review of the literature

Case

Reference

Age

Sex

Follow-up/survival (months)

Treatment

Tumor localization

1

Yamaguchi et al. 2007 [9]

14

m

8 (s)

-Etoposide

Disseminated BM infiltration, not specified

-Cyclophosphamide

-Pirarubicin

-Cisplatin

-Vincristine

2

Jani et al. (2009) [7]

16

m

8 (s)

-VP16

Disseminated BM infiltration, not specified

-Ifosfamide

-Vincristine

-Adriamycin

-Cyclophosphamide

3

Kern et al. (2015) [10]

52

f

12 (s)

Not detailed

BM infiltration, not specified

4

Karagiannis et al. (2015) [8]

61

f

7 (f)

-Topotecan

BM infiltration, not specified

-Cyclophosphamide

-Vinorelbine (Monotherapy-later)

5

Case 1 (current report)

17

m

7 (s)

-Ifosfamid

Diffuse BM infiltration

-Carboplatin

-Etoposid

-Vincristin

6

Case 2 (current report)

9

m

30 (s)

-Ifosfamid

Tibia, femur, pelvic bones, vertebrae

-Etoposid

-Carboplatin

-Topotecan

  1. The subtype has been evaluated in each case with molecular diagnostic tools (FISH, Sanger sequencing, spectral karyotyping, cytogenetics)
  2. BM bone marrow, s survival, f follow-up